731 related articles for article (PubMed ID: 10180333)
1. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
Creyer EH; Hrsistodoulakis I
Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with physicians' reliance on pharmaceutical sales representatives.
Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
[TBL] [Abstract][Full Text] [Related]
3. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians.
Spiller LD; Wymer WW
Health Mark Q; 2001; 19(1):91-106. PubMed ID: 11727295
[TBL] [Abstract][Full Text] [Related]
4. Details, details: what your colleagues think of drug reps.
Murray D
Med Econ; 2002 Jun; 79(11):41-4. PubMed ID: 12096597
[No Abstract] [Full Text] [Related]
5. Sales reps: footsoldiers in drug company wars.
Prescrire Int; 2004 Jun; 13(71):116. PubMed ID: 15233155
[No Abstract] [Full Text] [Related]
6. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
Gaedeke RM; Tootelian DH; Sanders EE
Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical drug marketing strategies and tactics: a comparative analysis of attitudes held by pharmaceutical representatives and physicians.
Parker RS; Pettijohn CE
Health Mark Q; 2005; 22(4):27-43. PubMed ID: 16597582
[TBL] [Abstract][Full Text] [Related]
8. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.
Sarikaya O; Civaner M; Vatansever K
Adv Health Sci Educ Theory Pract; 2009 Dec; 14(5):713-24. PubMed ID: 19184498
[TBL] [Abstract][Full Text] [Related]
9. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
[TBL] [Abstract][Full Text] [Related]
10. Why lunch matters: assessing physicians' perceptions about industry relationships.
Fugh-Berman AJ; Scialli AR; Bell AM
J Contin Educ Health Prof; 2010; 30(3):197-204. PubMed ID: 20872775
[TBL] [Abstract][Full Text] [Related]
11. The influence of pharmaceutical companies.
Messmer JJ
J Fam Pract; 2000 Dec; 49(12):1154; author reply 1155. PubMed ID: 11132069
[No Abstract] [Full Text] [Related]
12. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
Gülöksüz S; Oral ET; Ulaş H
Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
[TBL] [Abstract][Full Text] [Related]
13. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Castresana L; Mejia R; Aznar M
Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
[TBL] [Abstract][Full Text] [Related]
14. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
15. [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].
Ben Abdelaziz A; Harrabi I; Rahmani S; Ghedira A; Gaha K; Ghannem H
East Mediterr Health J; 2003; 9(5-6):1075-83. PubMed ID: 16450540
[TBL] [Abstract][Full Text] [Related]
16. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities for personal selling.
Powers TL; Bowers MR
J Health Care Mark; 1992 Dec; 12(4):26-32. PubMed ID: 10123582
[TBL] [Abstract][Full Text] [Related]
18. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
Anadaleeb SS; Tallman RF
Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
[TBL] [Abstract][Full Text] [Related]
19. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Johar K
Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
[No Abstract] [Full Text] [Related]
20. A national survey on the effect of pharmaceutical promotion on medical students.
Vainiomäki M; Helve O; Vuorenkoski L
Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
